Ambispective Observational Multicenter Study on the Efficacy of the Third Dose of Vaccine Anti COVID-19 in Patients Suffering From Solid Tumors Undergoing Oncological Treatment Active.

Oncologic Complications Clinical Trial

Official title:
Ambispective Observational Multicenter Study on the Efficacy of the Third Dose of Vaccine Anti COVID-19 in Patients Suffering From Solid Tumors Undergoing Oncological Treatment Active.

Status Completed

Clinical Trial Summary

To evaluate the serum neutralizing antibody titre in cancer patients undergoing active treatment against variants (VOC) before and after the third dose of BNT162b2 COVID-19 vaccine.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Oncologic Complications

Clinical Trial Details

NCT number	NCT06334744
Study type	Observational
Source	Fondazione IRCCS Policlinico San Matteo di Pavia
Contact
Status	Completed
Phase
Start date	November 17, 2021
Completion date	June 8, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04940780` - Integrative Oncology for Patient Symptoms	N/A
Completed	`NCT04506125` - Liberal Versus Restrictive Transfusion Threshold in Oncologic surgerY	N/A
Terminated	`NCT04155008` - Nutrition and Pharmacological Algorithm for Oncology Patients Study	Phase 4
Recruiting	`NCT03882580` - Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care
Withdrawn	`NCT04723108` - Virtual Reality for Chemotherapy Patients	N/A
Completed	`NCT04168814` - Nutritional Status in Locally Advanced or Metastatic Solid Cancer Patients in Spain: the NutriOncoSearch (NOS) Study
Completed	`NCT05529680` - Impact of Scapular Mobilization And Strengthening Exercises on Shoulder Function Post Mastectomy	N/A
Recruiting	`NCT05710809` - The SaVe Project-Sarcopenia and Vertigo in Aging Patients With Colorectal Cancer	N/A